Author Correction: Antibody responses to the RTS,S/AS01E vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in Mozambique.
Saved in:
| Title: | Author Correction: Antibody responses to the RTS,S/AS01 |
|---|---|
| Authors: | Sánchez L; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.; UnivLyon, Université Claude Bernard Lyon 1, 69100, Villeurbanne, France., Vidal M; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain., Jairoce C; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique., Aguilar R; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain., Ubillos I; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain., Cuamba I; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique., Nhabomba AJ; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique., Williams NA; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain., Díez-Padrisa N; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain., Cavanagh D; Institute of Immunology & Infection Research and Centre for Immunity, Infection & Evolution, Ashworth Laboratories, School of Biological Sciences, University of Edinburgh, King's Buildings, Edinburgh, UK., Angov E; U.S. Military Malaria Vaccine Program, Walter Reed Army Institute of Research (WRAIR), Silver Spring, MD, USA., Coppel RL; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Melbourne, VIC, Australia., Gaur D; Malaria Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India.; Laboratory of Malaria and Vaccine Research, School of Biotechnology, Jawaharlal Nehru University, New Delhi, India., Beeson JG; Burnet Institute, Melbourne, VIC, Australia., Dutta S; U.S. Military Malaria Vaccine Program, Walter Reed Army Institute of Research (WRAIR), Silver Spring, MD, USA., Aide P; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique., Campo JJ; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique., Moncunill G; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain. gemma.moncunill@isglobal.org.; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique. gemma.moncunill@isglobal.org., Dobaño C; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain. carlota.dobano@isglobal.org.; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique. carlota.dobano@isglobal.org. |
| Source: | NPJ vaccines [NPJ Vaccines] 2022 Aug 08; Vol. 7 (1), pp. 91. Date of Electronic Publication: 2022 Aug 08. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Springer Nature in partnership with the Sealy Center for Vaccine Development Country of Publication: England NLM ID: 101699863 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-0105 (Electronic) Linking ISSN: 20590105 NLM ISO Abbreviation: NPJ Vaccines Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
